Role of 12/15-lipoxygenase in nitrosative stress and peripheral prediabetic and diabetic neuropathies
Research output: Contribution to journal › Article
This study evaluated the role of 12/15-lipoxygenase, which converts arachidonic acid to 12(S)- and 15(S)-hydroxyeicosatetraenoic acids, in nitrosative stress in the peripheral nervous system and peripheral prediabetic and diabetic neuropathies. The experiments were performed in C57BL6/J mice made diabetic with streptozotocin or fed a high-fat diet and in human Schwann cells cultured in 5.5 or 30 mM glucose. 12/15-Lipoxygenase overexpression and activation were present in sciatic nerve and spinal cord of diabetic and high-fat diet-fed mice, as well as in human Schwann cells cultured in high concentrations of D-, but not L-glucose. 12/15-Lipoxygenase inhibition by cinnamy1-3,4-dihydroxy-alpha-cyanocinnamate (8 mg kg(-1) day(-1) Sc, for 4 weeks after 12 weeks without treatment) alleviated the accumulation of nitrated proteins in the sciatic nerve and spinal cord, and large and small nerve fiber dysfunction, but not intraepidermal nerve fiber loss. 12/15-Lipoxygenase gene deficiency alleviated nitrosative stress and nerve conduction deficit, but not small sensory fiber neuropathy, in high-fat-diet-fed mice. In conclusion, 12/15-lipoxygenase is implicated in nitrosative stress and peripheral neuropathy in mouse models of type 1 and early type 2 diabetes. Its presence in human Schwann cells and upregulation by high glucose suggest a potential involvement in human disease. (C) 2010 Elsevier Inc. All rights reserved.
|Number of pages||10|
|Journal||Free Radical Biology and Medicine|
|Publication status||Published - 1 Sep 2010|
- 12(S)-Hydroxyeicosatetraenoic acid, Tactile allodynia, Peripheral diabetic neuropathy, Free radicals, Thermal algesia, Human Schwann cell, Nerve conduction, Intraepidermal nerve fiber density, 12/15-Lipoxygenase, Nitrosative stress